Mundipharma expands Osteoarthritis gene therapy to more APAC countries
Invossa-K is a non-surgical treatment for osteoarthritis pain with long-term efficacy that has been hailed as the world’s first cell-mediated gene therapy for the dis...
IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.